Pharmaceutical giant Pfizer is under fire for deciding not to act on data suggesting that the rheumatoid arthritis drug Enbrel may be useful for preventing or treating Alzheimer’s.

Add comment

Your email address will not be published. Required fields are marked *

Follow Us